YEWB — Yew Bio-Pharm Balance Sheet

0.000.00%

Last trade - 00:00

Basic MaterialsHighly SpeculativeMicro Cap

Annual balance sheet for Yew Bio-Pharm, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2016 December 31st	C2017 December 31st	2018 December 31st	2019 December 31st	2020 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-Q	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.279	0.86	0.522	0.742	0.564
Net Total Accounts Receivable
Net Total Receivables	23.1	31.9	5.58	8.23	9.32
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	33.8	35.4	12.4	11.7	9.99
Net Property, Plant And Equipment	0.692	0.58	0.519	0.875	0.823
Net Intangible Assets
Other Long Term Assets
Total Assets	46.2	52.9	49.7	54.2	58.4
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	7.5	7.4	7.06	10.5	10.5
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	7.62	7.76	8.61	12.8	13
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	38.6	45.2	41.1	41.4	45.5
Total Liabilities & Shareholders' Equity	46.2	52.9	49.7	54.2	58.4
Total Common Shares Outstanding